US Stock MarketDetailed Quotes

ATHE Alterity Therapeutics

Watchlist
  • 2.2000
  • +0.1000+4.76%
Close Dec 20 16:00 ET
  • 2.2000
  • 0.00000.00%
Post 20:01 ET
19.23MMarket Cap-1.13P/E (TTM)

About Alterity Therapeutics Company

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Company Profile

SymbolATHE
Company NameAlterity Therapeutics
Listing DateSep 5, 2002
Founded1997
CEODr. David A. Stamler,M.D.
MarketNASDAQ
Employees10
Securities TypeDR
ADS Ratio1.0 : 600.0
Fiscal Year Ends06-30
Address350 Collins Street,Level 14,Suite 4
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9349-4906

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David A. Stamler,M.D.
  • Chief Executive Officer
  • 1.42M
  • Phillip A. Hains
  • Company Secretary and Chief Financial Officer
  • --
  • Geoffrey Paul Kempler
  • Chairman of the Board
  • 280.00K
  • Lawrence B. Gozlan
  • Director
  • 70.00K
  • Peter A. Marks
  • Independent Director
  • 70.00K
  • Brian Derek Meltzer
  • Independent Director
  • 70.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.